Description

3-Cyclopropyl-1-(2-[(2-Methoxyethyl)Amino]-2-Oxoethyl)-6-Methyl-1H-Pyrazolo[3,4-B]Pyridine-4-Carboxylic Acid is a high-purity, advanced pharmaceutical intermediate with a complex heterocyclic structure. This compound is of significant value for research and development in medicinal chemistry, particularly in the synthesis of novel therapeutic agents. It is primarily required by pharmaceutical R&D laboratories and fine chemical manufacturers engaged in developing new active pharmaceutical ingredients (APIs) and drug candidates.

Application

• Pharmaceutical Intermediate: Key building block in the synthesis of novel drug candidates targeting various disease pathways.
• Medicinal Chemistry Research: Used in structure-activity relationship (SAR) studies and lead optimization for new therapeutic molecules.
• API Development: Serves as a critical precursor in the multi-step synthesis of complex active pharmaceutical ingredients.
• Biochemical Research: Potential tool compound for investigating biological targets and enzymatic interactions in vitro.
• Fine Chemical Synthesis: Employed in custom synthesis and contract manufacturing for specialized chemical entities.

Basic Information

Product Name	3-Cyclopropyl-1-(2-[(2-Methoxyethyl)Amino]-2-Oxoethyl)-6-Methyl-1H-Pyrazolo[3,4-B]Pyridine-4-Carboxylic Acid
CAS No.	1018142-80-7
Molecular Formula	C18H22N4O4
Molecular Weight	358.40 g/mol
Synonyms	1H-Pyrazolo[3,4-b]pyridine-4-carboxylic acid, 3-cyclopropyl-1-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-6-methyl-; 3-Cyclopropyl-6-methyl-1-[2-[(2-methoxyethyl)amino]-2-oxoethyl]-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid; UNII-4J1T3W6Q6F; 4J1T3W6Q6F; CHEMBL3186660; AKOS025147064; ZINC000004169756; SCHEMBL15406297
EINECS	Contact for details

Quality Control

Our production of this advanced intermediate adheres to strict quality management systems. Each batch undergoes comprehensive analytical testing, including HPLC for purity and identity confirmation via NMR and mass spectrometry, to ensure it meets the exacting standards required for pharmaceutical R&D. A detailed Certificate of Analysis (COA) is provided with every shipment, documenting all critical quality attributes.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). The compound may be hygroscopic (moisture-sensitive); therefore, the container must be kept tightly sealed under an inert atmosphere if specified. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.